The successful development of new medicines and combinations is becoming increasingly reliant on harnessing an alliance ecosystem. As the rate of pharmaceutical and biotech partnering continues to rise, alliance management, and the development of an organization’s alliance capability, have evolved into critical components for successful execution and maximized value of each partnership. Yet alliance managers are often confronted with myriad challenges, including managing increasingly complex and distinct types of partnerships, dealing with integrations or divestments, overcoming corporate and cultural diversity, as well as navigating organizational restructuring, team turnover and partnership termination. The need for effective methods to systematically manage biopharma partnerships throughout their entire lifecycle continues to drive and shape the discipline of alliance management. Cambridge Healthtech Institute’s 14th Annual Strategic Alliance Management Congress, May 1-3, brings together senior alliance management, business development, technology transfer and licensing professionals, to network, share experiences, discuss case studies, and share the components that cultivate successful partnerships. Delegates will gain strategic insights, proven tools, methods, and perspectives from a variety of leaders advancing the art of alliance management.